WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Elizabeth A. GarofaloDirector2024-03-081,408$46.16
$64.99kSell
Elizabeth A. GarofaloDirector2024-03-083,500$18.56
$64.96kBuy
Elizabeth A. GarofaloDirector2024-03-082,092$45.69
$95.58kSell
Steven GannonDirector2024-03-075,000$46.30
$231.52kSell
Steven GannonDirector2024-03-075,000$46.25
$231.25kSell
Steven GannonDirector2024-03-071,000$46.45
$46.45kSell
Sherrington RobinEVP Strategy Innovation2024-03-071,234$9.85
$12.15kBuy
Sherrington RobinEVP Strategy Innovation2024-03-07215$45.96
$9.88kSell
Sherrington RobinEVP Strategy Innovation2024-03-077,407$9.85
$72.96kBuy
Sherrington RobinEVP Strategy Innovation2024-03-071,019$46.15
$47.03kSell

1 of 7

XENE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Avoro Capital Advisors LLC7.51%5,666,666$243.67MInstitution
Fmr LLC7.50%5,655,922$243.20MInstitution
Driehaus Capital Management LLC5.76%4,345,180$186.84MInstitution
Wellington Management Group LLP5.52%4,162,654$178.99MInstitution
Polar Capital Holdings PLC4.07%3,066,628$131.87MInstitution
Capital World Investors3.55%2,681,537$115.31MInstitution
Capital International Investors3.26%2,455,683$105.59MInstitution
Commodore Capital LP2.87%2,167,793$93.22MInstitution
Paradigm Biocapital Advisors LP2.82%2,127,400$91.48MInstitution
Blackrock Inc2.74%2,067,063$88.88MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE95.45%3.29%Net SellingNet Selling
IMCR75.26%0.07%Net BuyingNet Buying
CRNX85.02%14.98%Net SellingNet Selling
IDYA88.70%10.03%Net BuyingNet Selling
MLTX72.47%27.53%Net BuyingNet Selling

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 95.45% institutional shareholders, 3.29% Xenon Pharmaceuticals insiders, and 1.26% retail investors. Evan A. Stein is the largest individual Xenon Pharmaceuticals shareholder, owning 1.04M shares representing 1.38% of the company. Evan A. Stein's Xenon Pharmaceuticals shares are currently valued at $44.95M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.